Mirugen is a preclinical biotechnology company identifying the optimal set of cellular instructions ('transcription factors') to ask one cell type to become another. Our lead program is focused on unlocking innate repair mechanisms to restore sight, initially for the 1.5 million individuals worldwid...See more
Headquarters:
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2022 (3 years)
Address:
null
LOW
spending power
